JOJoy Isioma Oraegbu

Joy Isioma Oraegbu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joy Isioma Oraegbu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Influence of Gut Microbiota on Pregnancy Outcome Among HIV-infected Women in Lagos, Nigeria

    by Joy Isioma Oraegbu

    Background Gut microbiota plays a crucial role in maternal metabolism, immune regulation, and pregnancy outcomes. However, HIV infection disrupts gut microbiota diversity, potentially leading to adverse pregnancy outcomes. Nigeria bears a high burden of HIV among pregnant women, yet the relationship between gut microbiota diversity and pregnancy outcomes in this population remains underexplored. Objective This study aimed to investigate the association between gut microbiome diversity and pregnancy outcomes among HIV-infected pregnant women in Lagos, Nigeria. Methods A comparative cross-sectional study was conducted involving 100 pregnant women (50 HIV-positive and 50 HIV-negative) in Lagos, Nigeria. Socio-demographic, clinical, and dietary data were collected using structured questionnaires. Blood samples were analyzed for CD4 count, HIV viral load, and co-infections (HBV and HCV). Fecal samples underwent microbial culture and 16S rRNA sequencing for gut microbiota characterization at the Centre for Human Virology and Genomics, Nigerian Institute of Medical Research. Pregnancy outcomes were assessed and compared between the two groups. Results HIV-infected pregnant women exhibited significantly reduced gut microbial diversity and a higher prevalence of Candida albicans (78% vs. 20%; p < 0.001) compared to HIV-uninfected women. Adverse pregnancy outcomes, including low birth weight (30% vs. 7.7%; p = 0.004) and preterm birth, were more frequent among HIV-infected women. Proteus mirabilis was significantly associated with adverse pregnancy outcomes in the HIV-positive group (p = 0.023). The HIV-positive group also had lower immune status, with 20% showing CD4 counts below 350 cells/µL compared to 2% in the HIV-negative group (p = 0.004). Hepatitis B surface antigen (HBsAg) positivity was higher in HIV-positive pregnant women (16%) than in HIV-negative women (2%; p = 0.012). Dietary intake varied, with HIV-infected women consuming fewer dairy products and less folic acid supplementation. Conclusion This study highlights the complex interplay between HIV-associated gut dysbiosis and adverse pregnancy outcomes. Modulation of the gut microbiota, alongside antiretroviral therapy, may improve maternal and neonatal health outcomes. These findings provide valuable insight into the microbiome’s role in pregnancy among HIV-infected populations in Nigeria and suggest potential therapeutic targets for reducing pregnancy complications.

  • Open Access

    Assessment of awareness and levels of preparedness for humanitarian disasters across some geopolitical zones in Nigeria

    by O. S. Amoo, O. B. Awoderu, B. Moses, E. E. Afocha, A. M. Adedeji, M. B. Ajayi, T. A. Bamidele, C. T. Oparaugo, W. Fesobi, M. A. Fowora, et al.


  • Open Access

    Regional Cross-Sectional Based Study and Associated Risk Factors of Porcine Circovirus 2 in Nigerian Pigs

    by Kayode O. Afolabi, Olufemi S. Amoo, Tochukwu I. Onuigbo, Joy I. Oraegbu, Ayomikun A. Awoseyi, Folorunso O. Fasina, Oluwawemimo O. Adebowale

    Porcine circovirus 2 (PCV2) is a swine viral pathogen of substantial economic importance in pig farming globally. However, large-scale surveillance is needed to determine its prevalence and associated risk factors in the Nigerian pigs. We conducted molecular-based surveillance and mapping of PCV2 in southwest Nigeria to assess its prevalence and spatiality. Six hundred forty-eight individual fecal samples were collected from the different age groups of pigs from 67 farms in three southwest states. The polymerase chain reaction technique was used to screen the samples with a specific primer pair. The viral prevalence was determined at individual animal and farm levels. Overall, 145 out of 648 samples (22.4%) and 49/67 farms (73.1%) tested positive for PCV2. The highest prevalence of PCV2 was observed in Oyo State (63/185, 34.1%) and in growers (66/145, 45.5%). Restricting visitors’ entrance to the farm was found to be strongly protective for PCV2 (AOR 0.122; ; 95% CI; 0.027–0.564), while not having a quarantine protocol (AOR 4.445; ; 95% CI; 1.067–18.5280) and reporting coccidiosis as a common disease encountered (AOR 14.340; ; 95% CI; 2.094–98.203) on the farm were significant risk factors identified to be associated with the presence of PCV2. This study revealed a higher prevalence of PCV2 in Nigerian swine herds than expected and presented significant spatial clustering of infection in the studied region. It has also highlighted the risk factors driving its spread in the studied area. The research findings underscore the need for a policy decision to promote PCV2 vaccination in the country, which is currently not in place. The availability and use of the PCV2 vaccines, in addition to effective biosecurity measures, will help to mitigate the virus and its associated diseases in the country for sustainable and profitable pig farming, which holds vast potential in solving the problem of hunger and poverty.